IDEXX Laboratories, Inc. IDXX is set to release fourth-quarter 2025 results on Feb.2, before the opening bell. In the last reported quarter, the company posted adjusted earnings per share (EPS) of ...
Baron Fund, an investment management company, released its Q4 2025 letter for “Baron Partners Fund”. A copy of the letter can be downloaded here. The Fund increased considerably in the fourth quarter, ...
Most readers would already know that IDEXX Laboratories' (NASDAQ:IDXX) stock increased by 7.5% over the past three months. Given that the market rewards strong financials in the long-term, we wonder ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced two major advancements in veterinary cancer diagnostics: the expansion of its IDEXX Cancer Dx™ ...
IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the strong momentum in its CAG (Companion Animal Group) Diagnostics business. The company is also growing its ...
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the ImageVue™ DR50 Plus Digital Imaging System, ...
Shares of IDEXX Laboratories Inc. IDXX shed 1.01% to $687.74 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising ...
Shares of IDEXX Laboratories Inc. IDXX slid 4.10% to $686.02 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.06% to 6,796.86 ...
Cancer Dx expansion and inVue Dx FNA combine preventive screening and rapid, in-clinic diagnosis, enabling veterinarians and pet owners to act with confidence WESTBROOK, Maine — IDEXX Laboratories, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results